NCT04935762View on ClinicalTrials.gov

A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
Freezing of Gait Symptoms in Parkinson's Disease
Interventions
DRUG

CST-103, CST-107, matching placebo

CST-103 and matching placebo orange capsules; CST-107 and matching placebo white capsules

Trial Locations (1)

2006

The University of Sydney, Sydney

Sponsors
All Listed Sponsors
lead

CuraSen Therapeutics, Inc.

INDUSTRY

NCT04935762 - A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012) | Biotech Hunter | Biotech Hunter